BioMap denied commenting on media reports that the Baidu-backed life science AI startup is confidentially filing for a Hong Kong IPO to raise several hundred million dollars. BioMap partnered with Sanofi to co-develop AI modules for biologic drug discovery and worked with Fudan University to introduce the DNA foundation model EnTao-GPM last year.